Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment

Hua Zhao(West Virginia University), Yehenew M. Agazie(West Virginia University)

BMC Cancer

March 7, 2015

10.1186/s12885-015-1131-2

Cited by 20

Related Papers

MiR-133b Is Down-Regulated in Human Osteosarcoma and Inhibits Osteosarcoma Cells Proliferation, Migration and Invasion, and Promotes Apoptosis

|PLoS ONE|2013|107

SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer

|Breast Cancer Research|2016|52